These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11399898)

  • 1. A common phenotype associated with atherogenesis in diverse mouse models of vascular lipid lesions.
    Reckless J; Rubin EM; Verstuyft JB; Metcalfe JC; Grainger DJ
    J Vasc Res; 2001; 38(3):256-65. PubMed ID: 11399898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.
    Mallat Z; Gojova A; Marchiol-Fournigault C; Esposito B; Kamaté C; Merval R; Fradelizi D; Tedgui A
    Circ Res; 2001 Nov; 89(10):930-4. PubMed ID: 11701621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).
    Schneider DJ; Hayes M; Wadsworth M; Taatjes H; Rincón M; Taatjes DJ; Sobel BE
    J Histochem Cytochem; 2004 Aug; 52(8):1091-9. PubMed ID: 15258185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
    Krag S; Danielsen CC; Carmeliet P; Nyengaard J; Wogensen L
    Kidney Int; 2005 Dec; 68(6):2651-66. PubMed ID: 16316341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic deletion of tissue-type plasminogen activator (t-PA) in APOE3-Leiden mice reduces progression of cholesterol-induced atherosclerosis.
    Rezaee F; Gijbels M; Offerman E; Verheijen J
    Thromb Haemost; 2003 Oct; 90(4):710-6. PubMed ID: 14515193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways.
    Otsuka G; Agah R; Frutkin AD; Wight TN; Dichek DA
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):737-43. PubMed ID: 16373605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice.
    Grainger DJ; Kemp PR; Liu AC; Lawn RM; Metcalfe JC
    Nature; 1994 Aug; 370(6489):460-2. PubMed ID: 8047165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice.
    Luttun A; Lupu F; Storkebaum E; Hoylaerts MF; Moons L; Crawley J; Bono F; Poole AR; Tipping P; Herbert JM; Collen D; Carmeliet P
    Arterioscler Thromb Vasc Biol; 2002 Mar; 22(3):499-505. PubMed ID: 11884297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis.
    Belton OA; Duffy A; Toomey S; Fitzgerald DJ
    Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1.
    Schafer K; Müller K; Hecke A; Mounier E; Goebel J; Loskutoff DJ; Konstantinides S
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2097-103. PubMed ID: 14512369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressing thrombin generation is compatible with the development of atherosclerosis in mice.
    Grainger DJ; McWilliam NA; Baglin TP; Byrne CD
    Thromb Res; 2001 Apr; 102(1):71-80. PubMed ID: 11323017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques.
    Cipollone F; Fazia M; Mincione G; Iezzi A; Pini B; Cuccurullo C; Ucchino S; Spigonardo F; Di Nisio M; Cuccurullo F; Mezzetti A; Porreca E
    Stroke; 2004 Oct; 35(10):2253-7. PubMed ID: 15297631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression.
    Lutgens E; Gijbels M; Smook M; Heeringa P; Gotwals P; Koteliansky VE; Daemen MJ
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):975-82. PubMed ID: 12067907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered vascular remodeling in osteopontin-deficient atherosclerotic mice.
    Ström A; Franzén A; Wängnerud C; Knutsson AK; Heinegård D; Hultgårdh-Nilsson A
    J Vasc Res; 2004; 41(4):314-22. PubMed ID: 15218333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits.
    Ichikawa T; Unoki H; Sun H; Shimoyamada H; Marcovina S; Shikama H; Watanabe T; Fan J
    Am J Pathol; 2002 Jan; 160(1):227-36. PubMed ID: 11786416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification.
    Qiao JH; Xie PZ; Fishbein MC; Kreuzer J; Drake TA; Demer LL; Lusis AJ
    Arterioscler Thromb; 1994 Sep; 14(9):1480-97. PubMed ID: 8068611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta.
    Grainger DJ; Witchell CM; Metcalfe JC
    Nat Med; 1995 Oct; 1(10):1067-73. PubMed ID: 7489365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells.
    Otsuka G; Stempien-Otero A; Frutkin AD; Dichek DA
    Circ Res; 2007 May; 100(9):1300-7. PubMed ID: 17431190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis.
    Grainger DJ
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):399-404. PubMed ID: 14699019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis.
    Robertson AK; Rudling M; Zhou X; Gorelik L; Flavell RA; Hansson GK
    J Clin Invest; 2003 Nov; 112(9):1342-50. PubMed ID: 14568988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.